Reply to Slankamenac et al's Comprehensive Complication Index Validation Study
- PMID: 26079896
- DOI: 10.1097/SLA.0000000000001288
Reply to Slankamenac et al's Comprehensive Complication Index Validation Study
Comment in
-
Reply to: the "Reply to Slankamenac et al's Comprehensive Complication Index Validation Study (November 2014)".Ann Surg. 2016 Aug;264(2):e12. doi: 10.1097/SLA.0000000000001292. Ann Surg. 2016. PMID: 26079897 No abstract available.
Comment on
-
The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials.Ann Surg. 2014 Nov;260(5):757-62; discussion 762-3. doi: 10.1097/SLA.0000000000000948. Ann Surg. 2014. PMID: 25379846
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
